Breaking Therapeutic Inertia in Type 2 Diabetes: Active Detection of In-Patient Cases Allows Improvement of Metabolic Control at Midterm

Type 2 diabetes (T2D) exists in 25–40% of hospitalized patients. Therapeutic inertia is the delay in the intensification of a treatment and it is frequent in T2D. The objectives of this study were to detect patients admitted to surgical wards with hyperglycaemia (HH; fasting glycaemia > 140 mg/dL...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucas Martín, Anna M., Guanyabens, Elena, Zavala-Arauco, R., Chamorro, Joaquín, Granada, Maria Luisa, Mauricio, Didac, Puig-Domingo, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451772/
https://www.ncbi.nlm.nih.gov/pubmed/26089883
http://dx.doi.org/10.1155/2015/381415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451772/
https://www.ncbi.nlm.nih.gov/pubmed/26089883
http://dx.doi.org/10.1155/2015/381415

Ejemplares similares